Krsnaa Diagnostics Ratios

Krsnaa Diagnostics Ltd Ratios

The Krsnaa Diagnostics Ltd Ratios page provides a complete fundamental analysis of Krsnaa Diagnostics Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Krsnaa Diagnostics Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Krsnaa Diagnostics Ltd (NSE: KRSNAA, BSE: 543328) is currently trading at ₹587.65, with a market capitalization of ₹19.01B. As a major player in the Health services sector and Medical/Nursing services industry, Krsnaa Diagnostics Ltd remains a key stock for fundamental analysis using Krsnaa Diagnostics Ltd Ratios.

Krsnaa Diagnostics Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Krsnaa Diagnostics Ltd P/E ratio currently stands at 33.34, making it one of the most tracked metrics in Krsnaa Diagnostics Ltd Ratios.

Historically, the Krsnaa Diagnostics Ltd P/E ratio has shown strong fluctuations:

• 2024: 33.34
• 2023: 35.52
• 2022: 23.85
• 2021: 21.22
• 2020: 0

The decline in Krsnaa Diagnostics Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Krsnaa Diagnostics Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 2.87.

Historical P/B trend:

• 2024: 2.87
• 2023: 2.45
• 2022: 1.96
• 2021: 2.23

Krsnaa Diagnostics Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Krsnaa Diagnostics Ltd P/S ratio currently stands at 3.61, an important part of Krsnaa Diagnostics Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 3.61
• 2023: 3.26
• 2022: 3.04
• 2021: 3.19

The rising Krsnaa Diagnostics Ltd P/S ratio indicates improved revenue valuation by investors.

Krsnaa Diagnostics Ltd Price to Cash Flow Ratio (P/CF)

The Krsnaa Diagnostics Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 30.75.

Historical Krsnaa Diagnostics Ltd Price to Cash Flow Ratio:

• 2024: 30.75
• 2023: 90.46
• 2022: 18.27
• 2021: 11.23
• 2020: 0

The declining Krsnaa Diagnostics Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Krsnaa Diagnostics Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Krsnaa Diagnostics Ltd EV currently stands at ₹27.23B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 27.23B
• 2023: 20.04B
• 2022: 14.05B
• 2021: 12.5B

Krsnaa Diagnostics Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Krsnaa Diagnostics Ltd EV/EBITDA ratio is currently 14.20, a key metric in Krsnaa Diagnostics Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 14.20
• 2023: 13.75
• 2022: 11.33
• 2021: 9.45

Higher Krsnaa Diagnostics Ltd EV/EBITDA suggests premium valuation.

Krsnaa Diagnostics Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Krsnaa Diagnostics Ltd D/E ratio is currently 0.23, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.23
• 2023: 0.20
• 2022: 0.04
• 2021: 0.06

Krsnaa Diagnostics Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Krsnaa Diagnostics Ltd ROE currently stands at 9.17%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 9.17
• 2023: 7.34
• 2022: 8.73
• 2021: 14.93

Declining ROE indicates pressure on profitability.

Krsnaa Diagnostics Ltd Ratios Analysis Summary

The Krsnaa Diagnostics Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Krsnaa Diagnostics Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Krsnaa Diagnostics Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.